Literature DB >> 7651451

Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings.

R A Maricle1, J G Nutt, J H Carter.   

Abstract

Pilot data on mood and anxiety changes in 15 Parkinson's disease patients with motor fluctuations are described based on ratings every 30 min for 5 h bracketing a 2-h constant-rate levodopa infusion. Robust mood and anxiety effects slightly preceded but temporally paralleled fluctuations in motor tapping scores. Research nurse ratings blind to patient ratings corroborated the changes. The magnitude of changes in mood and anxiety scores did not correlate with the magnitude of changes in tapping scores. The findings of this uncontrolled study suggest mood and anxiety fluctuations may be a common and potentially important component of levodopa-induced fluctuations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651451     DOI: 10.1002/mds.870100316

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

Review 1.  Potential programming of dopaminergic circuits by early life stress.

Authors:  Ana-João Rodrigues; Pedro Leão; Miguel Carvalho; Osborne F X Almeida; Nuno Sousa
Journal:  Psychopharmacology (Berl)       Date:  2010-11-19       Impact factor: 4.530

2.  Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

Authors:  Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne A Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Peter V Rabins; Howard D Weiss; Laura Marsh
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

Review 3.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 4.  Neuropsychiatric aspects of Parkinson's disease: recent advances.

Authors:  Laura Marsh; Ariel Berk
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

Review 5.  Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.

Authors:  B K Young; R Camicioli; L Ganzini
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

6.  Anxiety and self-perceived health status in Parkinson's disease.

Authors:  Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne R Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Peter V Rabins; Howard D Weiss; Laura Marsh
Journal:  Parkinsonism Relat Disord       Date:  2011-02-02       Impact factor: 4.891

Review 7.  The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Authors:  Daniel Weintraub; Eugenia Mamikonyan
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-09       Impact factor: 4.105

Review 8.  Parkinson's disease and anxiety.

Authors:  K Walsh; G Bennett
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

9.  Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality.

Authors:  Jared T Hinkle; Kate Perepezko; Zoltan Mari; Laura Marsh; Gregory M Pontone
Journal:  Am J Geriatr Psychiatry       Date:  2018-01-31       Impact factor: 4.105

Review 10.  Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.

Authors:  Daniel Weintraub
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.